<VariationArchive VariationID="2712742" VariationName="NM_001360.3(DHCR7):c.322-1_334del" VariationType="Deletion" Accession="VCV002712742" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-20" DateCreated="2024-02-14" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2878891" VariationID="2712742">
      <GeneList>
        <Gene Symbol="DHCR7" FullName="7-dehydrocholesterol reductase" GeneID="1717" HGNC_ID="HGNC:2860" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11q13.4</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="71434411" stop="71448393" display_start="71434411" display_stop="71448393" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="71145456" stop="71159476" display_start="71145456" display_stop="71159476" Strand="-" />
          </Location>
          <OMIM>602858</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001360.3(DHCR7):c.322-1_334del</Name>
      <CanonicalSPDI>NC_000011.10:71442340:TGTACAGAAGCACCTG:TG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11q13.4</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="71442341" stop="71442354" display_start="71442341" display_stop="71442354" variantLength="14" positionVCF="71442340" referenceAlleleVCF="GTGTACAGAAGCACC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="71153387" stop="71153400" display_start="71153387" display_stop="71153400" variantLength="14" positionVCF="71153386" referenceAlleleVCF="GTGTACAGAAGCACC" alternateAlleleVCF="G" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.71442343_71442356del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.71442343_71442356del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.71153389_71153402del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.71153389_71153402del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012655.2" sequenceAccession="NG_012655" sequenceVersion="2" change="g.11078_11091del">
            <Expression>NG_012655.2:g.11078_11091del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001163817.2" sequenceAccession="NM_001163817" sequenceVersion="2" change="c.322-1_334del">
            <Expression>NM_001163817.2:c.322-1_334del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001360.3" sequenceAccession="NM_001360" sequenceVersion="3" change="c.322-1_334del" MANESelect="true">
            <Expression>NM_001360.3:c.322-1_334del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_340" sequenceAccession="LRG_340">
            <Expression>LRG_340:g.11078_11091del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001360.3(DHCR7):c.322-1_334del AND Smith-Lemli-Opitz syndrome" Accession="RCV003508244" Version="1">
        <ClassifiedConditionList TraitSetID="1873">
          <ClassifiedCondition DB="MedGen" ID="C0175694">Smith-Lemli-Opitz syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-06-12" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-06-12" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-02-14" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10677299</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">10995508</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11427181</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16199547</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17441222</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9634533</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1873" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4152" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Smith-Lemli-Opitz syndrome</ElementValue>
                <XRef ID="Smith-Lemli-Opitz+Syndrome/6648" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010035" DB="MONDO" />
                <XRef ID="43929004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SLO syndrome type 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">7-Dehydrocholesterol reductase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">RSH syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">LETHAL ACRODYSGENITAL SYNDROME</ElementValue>
                <XRef Type="MIM" ID="270400" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">POLYDACTYLY, SEX REVERSAL, RENAL HYPOPLASIA, AND UNILOBAR LUNG</ElementValue>
                <XRef Type="MIM" ID="270400" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">RUTLEDGE LETHAL MULTIPLE CONGENITAL ANOMALY SYNDROME</ElementValue>
                <XRef Type="MIM" ID="270400" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Smith-Lemli-Opitz syndrome type 1</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">SLOS</ElementValue>
                <XRef Type="MIM" ID="270400" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5683" />
                <XRef ID="5683" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Smith-Lemli-Opitz syndrome (SLOS) is a congenital multiple-anomaly / cognitive impairment syndrome caused by an abnormality in cholesterol metabolism resulting from deficiency of the enzyme 7-dehydrocholesterol (7-DHC) reductase. It is characterized by prenatal and postnatal growth restriction, microcephaly, moderate-to-severe intellectual disability, and multiple major and minor malformations. The malformations include distinctive facial features, cleft palate, cardiac defects, underdeveloped external genitalia in males, postaxial polydactyly, and 2-3 syndactyly of the toes. The clinical spectrum is wide; individuals with normal development and only minor malformations have been described.</Attribute>
                <XRef ID="NBK1143" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301322</ID>
                <ID Source="BookShelf">NBK1143</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23519317</ID>
              </Citation>
              <XRef ID="818" DB="Orphanet" />
              <XRef ID="C0175694" DB="MedGen" />
              <XRef ID="MONDO:0010035" DB="MONDO" />
              <XRef Type="MIM" ID="270400" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7952103" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="24116603|MedGen:C0175694" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004267431" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10677299</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10995508</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11427181</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17441222</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16199547</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9634533</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10677299</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the DHCR7 protein in which other variant(s) (p.Leu109Pro) have been determined to be pathogenic (PMID: 10677299, 10995508, 11427181, 17441222). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This variant has not been reported in the literature in individuals affected with DHCR7-related conditions. This variant is not present in population databases (gnomAD no frequency). This variant results in the deletion of part of exon 5 (c.322-1_334del) of the DHCR7 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in DHCR7 are known to be pathogenic (PMID: 9634533, 10677299).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DHCR7" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.71153387_71153400del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0175694" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7952103" TraitType="Disease" MappingType="XRef" MappingValue="C0175694" MappingRef="MedGen">
        <MedGen CUI="C0175694" Name="Smith-Lemli-Opitz syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

